Novartis

Novartis receives binding offer from Siemens Healthineers for molecular imaging business
Reuters
Sun, 08/25/24 - 11:02 pm
Novartis
M&A
Siemens Healthineers
molecular imaging
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Fierce Biotech
Thu, 08/22/24 - 11:18 am
Novartis
Chinook Therapeutics
kidney disease
venture capital
Versant Ventures
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Novartis loses initial bid to block generic of best-selling heart drug
Reuters
Mon, 08/12/24 - 05:57 pm
Novartis
legal
MSN Pharmaceuticals
Entresto
heart failure
generics
Novartis' Complement Inhibitor Fabhalta Approved for IgAN
Contract Pharma
Mon, 08/12/24 - 05:52 pm
FDA
Novartis
Fabhalta
primary IgA nephropathy
Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth
Fierce Pharma
Fri, 08/9/24 - 11:25 am
Sandoz
earnings
biosimilars
Humira
AbbVie
Novartis
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk
FDA approves Novartis' kidney disease drug
Reuters
Wed, 08/7/24 - 11:02 pm
Novartis
FDA
Fabhalta
kidney disease
paroxysmal nocturnal hemoglobinuria
Novartis, Viatris face new lawsuit over 'HeLa' cell misuse claims
Reuters
Mon, 08/5/24 - 11:12 pm
Novartis
Viatris
R&D
legal
Big Pharma-Backed Ribon Therapeutics Shuts Down Business Operations
BioSpace
Mon, 08/5/24 - 11:21 am
Ribon Therapeutics
AbbVie
JNJ
Novartis
Pfizer
PARP inhibitors
Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal
Fierce Biotech
Wed, 07/24/24 - 11:09 pm
Novartis
Dren Bio
cancer
bispecifics
Merck, Rapt, Aslan and more cut staff
Pharma Live
Wed, 07/24/24 - 11:58 am
layoffs
Merck
RAPT Therapeutics
Aslan Pharma
Caribou Biosciences
Novartis
Spark Therapeutics
‘Not prudent’ for Novartis to join GLP-1 obesity race as late-runner, says CEO
Fierce Biotech
Thu, 07/18/24 - 11:13 pm
Novartis
Pharma CEOs
obesity
Vas Narasimhan
GLP-1 agonists
Novartis CEO sees IRA impact ‘manageable’ in short run, maintains midterm growth goal
Fierce Pharma
Thu, 07/18/24 - 11:02 pm
Novartis
Pharma CEOs
Vas Narasimhan
Inflation Reduction Act
Despite layoff announcements, Novartis beats Q2 expectations
BioSpace
Thu, 07/18/24 - 11:33 am
Novartis
layoffs
earnings
Novartis closes technical R&D site in San Diego as part of ongoing restructure
Fierce Biotech
Thu, 07/11/24 - 11:24 am
Novartis
R&D
San Diego
restructuring
Mississippi judge denies drug maker’s and PhRMA’s request for preliminary injunction in 340B case
American Hospital Association
Mon, 07/8/24 - 11:35 am
Novartis
PhRMA
340B
legal
Mississippi
Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage
Fierce Pharma
Fri, 06/14/24 - 11:40 am
Takeda
Novartis
Ascentage Pharma
olverembatinib
CML
The 6 largest biopharma layoffs of 2024 so far
BioSpace
Wed, 06/12/24 - 11:59 am
layoffs
Bristol Myers Squibb
Bayer
Takeda
Pfizer
Novartis
Perrigo
Behind Big Pharma’s layoffs — is there an end in sight?
Pharma Voice
Tue, 06/11/24 - 11:22 am
layoffs
Big Pharma
Bristol Myers Squibb
Takeda
Novartis
Bayer

Pages